|
1
|
Fasouliotis SJ, Simon A and Laufer N:
Evaluation and treatment of low responders in assisted reproductive
technology: a challenge to meet. J Assist Reprod Genet. 17:357–373.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shanbhag S, Aucott L, Bhattacharya S,
Hamilton MA and McTavish AR: Interventions for ‘poor responders’ to
controlled ovarian hyperstimulation (COH) in in-vitro fertilization
(IVF). Cochrane Database Syst Rev. 24:CD0043792007.
|
|
3
|
Kucuk T, Kozinoglu H and Kaba A: Growth
hormone co-treatment within a GnRH agonist long protocol in
patients with poor ovarian response: a prospective, randomized,
clinical trial. J Assist Reprod Genet. 25:123–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kyrou D, Kolibianakis EM, Venetis CA,
Papanilolaou EG, Bontis J and Tarlatzis BC: How to improve the
probability of pregnancy in poor responders undergoing in vitro
fertilization: a systrmatic review and meta-analysis. Fertil
Steril. 91:749–766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weil SJ, Vendola K, Zhou J, Adesanya OO,
Wang J, Okafor J and Bondy CA: Androgen receptor gene expression in
the primate ovary: cellular localization, regulation, and
functional correlations. J Clin Endocrinol Metab. 83:2479–2485.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vendola KA, Zhou J, Adesanya OO, Weil SJ
and Bondy CA: Androgens stimulate early stages of follicular growth
in the primate ovary. J Clin Invest. 101:2622–2629. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vendola K, Zhou J, Wang J, Famuyiwa OA,
Bievre M and Bondy CA: Androgens promote oocyte insulin-like growth
factor I expression and initiation of follicle development in the
primate ovary. Biol Reprod. 61:353–357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garcia-Velasco JA, Moreno L, Pacheco A,
Guillén A, Duque L, Requena A and Pellicer A: The aromatase
inhibitor letrozole increases the concentration of intraovarian
androgens and improves in vitro fertilization outcome in low
responder patients: a pilot study. Fertil Steril. 84:82–87. 2005.
View Article : Google Scholar
|
|
9
|
Higgins JPT and Green S: Cochrane Handbook
for Systematice Reviews of Interventions Version 5.1.0. (updated
March 2011). The Cochrane Collaboration; 2011, https://training.cochrane.org/handbook.
|
|
10
|
Moher D, Cook DJ, Eastwood S, Olkin I,
Rennie D and Stroup DF: Improving the quality of reports of
meta-analyses of randomised controlled trials: the QUOROM
statement. Quality of Reporting of Meta-analyses. Lancet.
354:1896–1900. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sackett DL: Rules of evidence and clinical
recommendations on the use of antithrombotic agents. Chest. 89(2
Suppl): 2S–3S. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balasch J, Fábregues F, Peñarrubia J,
Carmona F, Casamitjana R, Creus M, Manau D, Casals G and Vanrell
JA: Pretreatment with transdermal testosterone may improve ovarian
response to gonadotrophins in poor-responder IVF patients with
normal basal concentrations of FSH. Hum Reprod. 21:1884–1893. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Massin N, Cedrin-Durnerin I, Coussieu C,
Galey-Fontaine J, Wolf JP and Hugues JN: Effects of transdermal
testosterone application on the ovarian response to FSH in poor
responders undergoing assisted reproduction technique - a
prospective, randomized, double-blind study. Hum Reprod.
21:1204–1211. 2006. View Article : Google Scholar
|
|
15
|
Massin N, Cedrin-Durnerin I,
Galey-Fontaine J, Coussieu C, Bry-Gauillard H and Hugues JN: Is
androgen application beneficial for low responders. Hum Reprod.
19(Suppl 1): 120–121. 2004.
|
|
16
|
Feigenberg T, Simon A, Ben-Meir A,
Gielchinsky Y and Laufer N: Role of androgens in the treatment of
patients with low ovarian response. Reprod Biomed Online.
19:888–898. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sunkara SK, Pundir J and Khalaf Y: Effect
of androgen supplementation or modulation on ovarian stimulation
outcome in poor responders: a meta-analysis. Reprod Biomed Online.
22:545–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gleicher N and Barad DH: Androgen priming
before ovarian stimulation for IVF. Hum Reprod. 23:2868–2870. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sipe CS and Van Voorhis BJ: Testosterone
patch improves ovarian follicular response to gonadotrophins in a
patient with Kallmann’s syndrome: a case report. Hum Rerod.
22:1380–1383. 2007.PubMed/NCBI
|
|
20
|
Sipe CS, Thomas MR, Stegmann BJ and Van
Voorhis BJ: Effects of exogenous testosterone supplementation in
gonadotrophin stimulated cycles. Hum Reprod. 25:690–696. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim CH, Howles CM and Lee HA: The effect
of transdermal testosterone gel pretreatment on controlled ovarian
stimulation and IVF outcome in low responders. Fertil Steril.
95:679–683. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fábregues F, Peñarrubia J, Creus M, Manau
D, Casals G, Carmona F and Balasch J: Transdermal testosterone may
improve ovarian response to gonadotrophins in low-responder IVF
patients: a randomized, clinical trial. Hum Reprod. 24:349–359.
2009.PubMed/NCBI
|
|
23
|
Barbieri RL, Sluss PM, Powers RD, McShane
PM, Vitonis A, Ginsburg E and Cramer DC: Association of body mass
index, age, and cigarette smoking with serum testosterone levels in
cycling women undergoing in vitro fertilization. Fertil Steril.
83:302–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fratarelli JL and Peterson EH: Effect of
androgen levels on in vitro fertilization cycles. Fertil Steril.
81:1713–1714. 2004. View Article : Google Scholar : PubMed/NCBI
|
